Antibodies Drug Market Companies and their Innovations
The global antibodies drug market size was calculated at USD 245.75 billion in 2024, to reach USD 272.3 billion in 2025 is expected to be worth USD 685.33 billion by 2034, expanding at a CAGR of 10.8% from 2024 to 2034.
Antibodies Drug Companies:
- Roche
- AbbVie
- Johnson & Johnson
- Seagen
- Genmab
- Boehringer Ingelheim
- BioLegend (a PerkinElmer company)
Antibodies Drug Market: U.S. Pharmaceutical Shipments and Consignees Overview
| CONSIGNEE NAME | SHIPPER NAME | PRODUCT DESCRIPTION | QUANTITY | WEIGHT |
| TIME CAP LABS INC | MARKSANS PHARMA LIMITED | PHARMACEUTICAL PRODUCTS NIGHTTIME ANISE FLAVOR PLAIN | 2788 | 15160 |
| UPS SUPPLY CHAIN SOLUTIONS | LUPIN LIMITED | 1206 CARTONS (IN 40 PACKAGES) | 40 | 10597 |
| RISING PHARMA HOLDINGS INC | AUROBINDO PHARMA LIMITED | CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS | 40 | 9342 |
| USA FORMULATIONS LLC | AMOL PHARMACEUTICALS PRIVATE LIMITED | 40 PALLETS FORTY PALLETS S.B NO 6200424 DT. 05-DEC-2024 PHARMACEUTICAL TABLETS AZO URINARY TRACT DEFENSE METHENAMINE AND SODIUM SALICYLATE TABLETS | 40 | 6921 |
| AMNEAL PHARMACEUTICALS LLC | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | PHARMA HTS: 300490 | 20 | 10475 |
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking